Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities

Although nonalcoholic fatty liver disease (NAFLD) is associated with obesity, it can also occur in lean and metabolically normal individuals. Our aim was to determine the effect of different combinations of abdominal adiposity and overall adiposity on the mortality of NAFLD. The Third National Healt...

Full description

Bibliographic Details
Main Authors: Pegah Golabi, James M. Paik, Tamoore Arshad, Youssef Younossi, Alita Mishra, Zobair M. Younossi
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Hepatology Communications
Online Access:https://doi.org/10.1002/hep4.1534
id doaj-93d73d367a8c4d48b2780ee4cbb5d1aa
record_format Article
spelling doaj-93d73d367a8c4d48b2780ee4cbb5d1aa2020-11-25T03:12:26ZengWileyHepatology Communications2471-254X2020-08-01481136114810.1002/hep4.1534Mortality of NAFLD According to the Body Composition and Presence of Metabolic AbnormalitiesPegah Golabi0James M. Paik1Tamoore Arshad2Youssef Younossi3Alita Mishra4Zobair M. Younossi5Betty and Guy Beatty Center for Integrated Research, Inova Health System Inova Health System Falls Church VABetty and Guy Beatty Center for Integrated Research, Inova Health System Inova Health System Falls Church VACenter For Liver Diseases Department of Medicine Inova Fairfax Medical Campus Falls Church VACenter for Outcomes Research in Liver Diseases Washington DCCenter For Liver Diseases Department of Medicine Inova Fairfax Medical Campus Falls Church VABetty and Guy Beatty Center for Integrated Research, Inova Health System Inova Health System Falls Church VAAlthough nonalcoholic fatty liver disease (NAFLD) is associated with obesity, it can also occur in lean and metabolically normal individuals. Our aim was to determine the effect of different combinations of abdominal adiposity and overall adiposity on the mortality of NAFLD. The Third National Health and Nutrition Examination Survey with mortality data from the National Death Index were used. NAFLD was defined as steatosis without other liver diseases. Body composition was categorized according to waist circumference (WC) and body mass index (BMI). Obesity pattern was defined according to BMI (lean, overweight, and obese) and WC (normal and obese) using accepted definitions. The “metabolically abnormal” group had visceral obesity, insulin resistance, type 2 diabetes, hypertension, or hyperlipidemia. Of the 9,341 study individuals (47.9% male; 76.8% white), NAFLD was present in 3,140 (33.6%), of whom 0.6% had lean BMI and normal WC, and 1.7% had lean BMI and obese WC. The prevalence of metabolically normal NAFLD was 3.26% (95% confidence interval [CI]: 2.62%‐3.90%), with most of these subjects having lean BMI (79.2%). During an average follow‐up of 22.4 years, 24.1% of the subjects died from all causes. Among these deceased individuals, 41.7% had NAFLD at baseline. Causes of death were cardiovascular disease (24.8%), cancer‐related (24.3%), type 2 diabetes–related (4.4%), and liver‐related (1.7%). Individuals with NAFLD who were lean by BMI but obese by WC had higher risk of all‐cause mortality. Individuals with NAFLD with normal BMI but obese WC had a higher risk of cardiovascular mortality (hazard ratio 2.63 [95% CI: 1.15‐6.01]) as compared with overweight (by BMI) NAFLD with normal WC. Conclusion: The risk of mortality in NAFLD can be affected by the presence of visceral obesity, especially in the lean BMI group. These data have important management implications for patients with NAFLD.https://doi.org/10.1002/hep4.1534
collection DOAJ
language English
format Article
sources DOAJ
author Pegah Golabi
James M. Paik
Tamoore Arshad
Youssef Younossi
Alita Mishra
Zobair M. Younossi
spellingShingle Pegah Golabi
James M. Paik
Tamoore Arshad
Youssef Younossi
Alita Mishra
Zobair M. Younossi
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities
Hepatology Communications
author_facet Pegah Golabi
James M. Paik
Tamoore Arshad
Youssef Younossi
Alita Mishra
Zobair M. Younossi
author_sort Pegah Golabi
title Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities
title_short Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities
title_full Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities
title_fullStr Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities
title_full_unstemmed Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities
title_sort mortality of nafld according to the body composition and presence of metabolic abnormalities
publisher Wiley
series Hepatology Communications
issn 2471-254X
publishDate 2020-08-01
description Although nonalcoholic fatty liver disease (NAFLD) is associated with obesity, it can also occur in lean and metabolically normal individuals. Our aim was to determine the effect of different combinations of abdominal adiposity and overall adiposity on the mortality of NAFLD. The Third National Health and Nutrition Examination Survey with mortality data from the National Death Index were used. NAFLD was defined as steatosis without other liver diseases. Body composition was categorized according to waist circumference (WC) and body mass index (BMI). Obesity pattern was defined according to BMI (lean, overweight, and obese) and WC (normal and obese) using accepted definitions. The “metabolically abnormal” group had visceral obesity, insulin resistance, type 2 diabetes, hypertension, or hyperlipidemia. Of the 9,341 study individuals (47.9% male; 76.8% white), NAFLD was present in 3,140 (33.6%), of whom 0.6% had lean BMI and normal WC, and 1.7% had lean BMI and obese WC. The prevalence of metabolically normal NAFLD was 3.26% (95% confidence interval [CI]: 2.62%‐3.90%), with most of these subjects having lean BMI (79.2%). During an average follow‐up of 22.4 years, 24.1% of the subjects died from all causes. Among these deceased individuals, 41.7% had NAFLD at baseline. Causes of death were cardiovascular disease (24.8%), cancer‐related (24.3%), type 2 diabetes–related (4.4%), and liver‐related (1.7%). Individuals with NAFLD who were lean by BMI but obese by WC had higher risk of all‐cause mortality. Individuals with NAFLD with normal BMI but obese WC had a higher risk of cardiovascular mortality (hazard ratio 2.63 [95% CI: 1.15‐6.01]) as compared with overweight (by BMI) NAFLD with normal WC. Conclusion: The risk of mortality in NAFLD can be affected by the presence of visceral obesity, especially in the lean BMI group. These data have important management implications for patients with NAFLD.
url https://doi.org/10.1002/hep4.1534
work_keys_str_mv AT pegahgolabi mortalityofnafldaccordingtothebodycompositionandpresenceofmetabolicabnormalities
AT jamesmpaik mortalityofnafldaccordingtothebodycompositionandpresenceofmetabolicabnormalities
AT tamoorearshad mortalityofnafldaccordingtothebodycompositionandpresenceofmetabolicabnormalities
AT youssefyounossi mortalityofnafldaccordingtothebodycompositionandpresenceofmetabolicabnormalities
AT alitamishra mortalityofnafldaccordingtothebodycompositionandpresenceofmetabolicabnormalities
AT zobairmyounossi mortalityofnafldaccordingtothebodycompositionandpresenceofmetabolicabnormalities
_version_ 1724650377918283776